Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
14 New Monoclonal Anti-Cytokeratin Antibodies from AbboMax
AbboMax adds over a dozen new anti-cytokeratin monoclonal antibodies to its inventory. Cytokeratins are proteins found in epithelium. A variety of cytokeratins can be used for subtyping various forms of epithelial differentiation or for the detection of possible sites of origin of tumors. Primary tumors usually recapitulate the cytokeratin profiles of the cells from which they are derived. They are one of the most effective epithelial differentiation and tumor markers. - January 13, 2021 - AbboMax, Inc.
Ultra-Low Temperature Freezers for Vaccine and Laboratory Cold Storage Introduced by ATS
ATS announces both freestanding and portable freezers for vaccines, biological materials, and biomedical uses. The ultra-low temperature freezers can continuously store biological materials, including vaccines, at temperatures as low as -86°C (-123°F) with +/- 0.1°C accuracy. - January 07, 2021 - Advanced Thermal Solutions, Inc.
Stefan Przyborski from University of Durham Invites You to Join 3D Cell Culture Virtual Conference
SMi Reports: Conference Chairman invite letter released for SMi’s 5th Annual 3D Cell Culture Virtual Conference, taking place in February 2021. - January 06, 2021 - SAE Media Group
Bench International Launches "Bank of Women"
First of Its Kind Program Features 550+ Executive Women Leaders for Board Seats and the C-Suite - January 05, 2021 - Bench International
A Novel Treatment Modality for COVID-19: Global Cancer Technology is Developing a Nanoparticle Which May Selectively Target, Bind and Inactivate Coronavirus Virions
Global Cancer Technology, an emerging biopharmaceutical company, is developing a novel treatment modality to selectively kill the COVID-19 virus. - December 30, 2020 - Global Cancer Technology
Popular Music-Fitness App, RockMyRun Releases New Poll on Music and Exercise and the Five Best Workout Songs of All Time
RockMyRun recently released a poll that revealed the five best workout songs of all time along with details on how important music is to a great workout. Topping the list of all-time favorite workout jams are, We Will Rock You by Queen and Lose Yourself by Eminem. - December 25, 2020 - RockMyRun
United Capital Partners Sources $10MM Equipment Lease Line
United Capital sources $10MM equipment lease line for customer in the Biotech Industry. - December 18, 2020 - United Capital Partners
The US Oncology Network Warns Administration’s Most Favored Nation Model Will Disrupt Patient Access to Cancer Treatments
Interim Final Rule would disproportionately target oncologists and reduce patient access to current and future treatments. - November 24, 2020 - The US Oncology Network
Unique New Device to Self-Monitor COVID-19 Risk During Delay Between Tests, from Centers for Age Control Inc.
Few people are able to take a COVID-19 test every day or even every week or month. A negative result can be useful on the day of the test, but a person will not know if infected later. The COVID-19 HealthMeter™ reduces that risk with daily noninvasive physiological self-monitoring of 16 COVID-19 indicators and risk factors, including functional age vs. birth age, high frequency hearing loss, mental confusion, short term memory, lungs, blood oxygen, heart rate, blood pressure, body fat, etc. - November 12, 2020 - Centers for Age Control Inc.
Erica Cai Named ALPCO’s Summer 2020 Diabetes Research Travel Grant Recipient
Today ALPCO announced Erica Cai from Harvard Medical School as the latest recipient of its Diabetes Research Travel Grant. Dr. Cai is a postdoctoral fellow from the Joslin Diabetes Center researching the mechanism of autoimmunity that leads to beta cell destruction and type 1 diabetes (T1D). Dr. - November 10, 2020 - ALPCO
New Rapid COVID-19 Point of Care Test
Pepex Biomedical has diverted funds and resources to the development of Multiple Rapid COVID-19 Tests designed to accurately identify Antigens (diagnostic to detect active virus) and Antibodies (to determine immunity) in under 15 minutes with 95% accuracy. - November 09, 2020 - Pepex Biomedical, Inc.
Cayman Breaks Ground on State-of-the-Art Facility Projecting Future Growth in R&D
Cayman held a groundbreaking ceremony to start the buildout of a $20 million research and development facility at its headquarters in Ann Arbor, MI. - November 07, 2020 - Cayman Chemical Company
ReproTech, Ltd. Presents Study on Important Considerations for Safe Cryogenic Shipping
ReproTech, Ltd. was honored to present an oral abstract at the virtual American Society for Reproductive Medicine (ASRM) 2020 Scientific Congress and Expo that resulted from a study designed by authors, W. Brent Hazelrigg, President and CEO; and Amy Erickson Hagen, Vice President of Quality... - October 29, 2020 - ReproTech, LLC
Artificial Intelligence Search Technology Will be Used to Help Modernize US Federal Pathology Facility
Technology developed by Canadian researchers has been adopted by the Joint Pathology Center (JPC), which has the world’s largest collection of preserved human tissue samples. The v=center will use an artificial intelligence (AI) search engine to index and search its digital archive as part of a modernization effort. The image search engine was designed by researchers at the Laboratory for Knowledge Inference in Medical Image Analysis (Kimia Lab) at the University of Waterloo. - October 28, 2020 - Kimia Lab, University of Waterloo
Cellulose Ethers Market Size, Share, and Forecast 2019-2027
The global cellulose ethers market is valued at USD 4,292.87 million in 2019 and is expected to grow at a CAGR of 4.83%. This rise in market value can be attributed to the increase in awareness regarding the benefits of cellulose ether and its derivatives increase in the number of oil drilling activities. - October 28, 2020 - DataM Intelligence 4Market Research
The Palm Beach Hedge Fund Association Announces a Strategic Partnership with Jupiter Orphan Therapeutic
Jupiter Orphan Therapeutics forms strategic partnership with The Palm Beach Hedge Fund Association. - October 15, 2020 - Palm Beach Hedge Fund Association
Volasertib, a Potential New Treatment for Rhabdomyosarcoma, Receives Orphan Drug Designation from the U.S. FDA
Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to volasertib for its use in treating pediatric rhabdomyosarcoma and other rare soft tissue sarcomas. Key... - October 15, 2020 - Oncoheroes Biosciences Inc.
Introducing EDI’s COVID-19 Nucleocapsid IgG Quantitative ELISA Kit
The EDI™ COVID-19 Nucleocapsid IgG Quantitative ELISA Kit is designed, developed & produced for the quantitative measurement of human anti-COVID-19 (anti-SARS-CoV-2) IgG antibody in serum. The test uses a series of calibrators & controls in order to determine a standard curve, which allows for specific, concentration-based results of patient samples, giving researchers & healthcare providers access to quantitative patient data in order to better understand a patient's current disease stage. - October 14, 2020 - Epitope Diagnostics, Inc.
ReproTech, Ltd. Celebrates 30 Years in Reproductive Cryostorage
ReproTech, Ltd. is celebrating 30 years as the first company dedicated solely to long-term reproductive tissue storage. Over three decades, ReproTech has expanded from one facility in St. Paul, MN to four regional locations in the United States including Fort Lauderdale, FL; Reno, NV; and... - October 14, 2020 - ReproTech, LLC
Veralize Device Team Named Semi-Finalist for XPRIZE Rapid COVID-19 Testing
Team made up of 12-15 Molecular Diagnostics, African Biosciences Ltd. and Ahmadu Bello University has been selected as semi-finalist in the XPRIZE Rapid COVID-19 Testing competition. The patented rapid response diagnostic device designed by 12-15 Molecular Diagnostics can detect COVID-19 using saliva samples. By algorithmically analyzing the results with the 12-15 Molecular Diagnostics machine learning system, the test can provide 95% accuracy and early detection, even when there are no symptom - October 13, 2020 - African Biosciences Inc.
XECAN Announces Its "Touchless" Facial Recognition Technology Can Identify and Verify Patients with or Without Masks on
Patients can be checked in and verified against the EMR system using facial recognition even if the patients have their masks on. - October 07, 2020 - XECAN
Southeastern Ohio Health Provider Partners with Medicom Health to Lower Medication Cost for Patients
New Electronic Medical Record Add-On Automates the Delivery of Rx Discounts at Enterprise Scale - October 06, 2020 - Medicom Health
Legionnaires’ Disease Cases Lead to Legionella Water Testing
Hyperion Offers Testing to Identify If Legionella Bacteria Are Growing in a Building’s Water System. - October 03, 2020 - Hyperion Biotechnology, Inc.
FDA Grants Rare Pediatric Disease Designation (RPDD) to Volasertib for Rhabdomyosarcoma
Oncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, is pleased to announce that the United States Food and Drug Administration (FDA) has granted the designation of rare pediatric disease to volasertib, an investigational treatment for rhabdomyosarcoma. Key... - September 25, 2020 - Oncoheroes Biosciences Inc.
Ampersand Capital Partners Acquires American Laboratory Products Company
American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support ALPCO’s worldwide growth initiatives, including the... - September 21, 2020 - ALPCO
WiCON Publishes the China Pharmaceutical Guide 2020 - Stabilizing Growth Amid Deepening Reform
WiCON International Group LLC, the publisher of well-known WiCON | Pharma China (www.pharmachinaonline.com), announced that its China Pharmaceutical Guide 2020 (15th Edition) is now published. The publication reports stabilizing Chinese pharma growth amid deepening healthcare and drug regulatory reform. - September 20, 2020 - WiCON International Group LLC
ViridisChem Expands Its Market Reach with Key Distribution Partnership in South Korea
ViridisChem, Inc. San Jose, CA (https://www.viridischem.com) is very excited to announce a strategic partnership with BITEK Chems, Inc. (http://www.bitekchems.com), a premier distributor in Korea that has been serving pharmaceutical and chemical companies, as well as government and educational... - September 19, 2020 - ViridisChem, Inc.
ViridisChem Announces Strategic Partnership with Infocom Corporation, Japan
ViridisChem, Inc. is pleased to announce a strategic partnership with Infocom Corporation, a highly regarded software distributor based in Tokyo, Japan that caters to research communities within the medical and pharmaceutical sectors with B2B software solutions since 1983. - September 17, 2020 - ViridisChem, Inc.
Oakbloc Launches Kalehdoo Clinical Intelligence for Various Stakeholders in the Clinical Trials Industry
Oakbloc announced the Launch of its Analytics product Kalehdoo Clinical Intelligence for Pharmaceutical Sponsors, CROs and special interest Organizations providing Market Analytics & Competitive Intelligence, Clinical Trials landscape and outlook, trends in clinical trial activity, trial design, and design outcomes. Insights driven approach for future prioritization. - September 17, 2020 - Oakbloc Technologies
BrainTrain Releases Test of Attention and Executive Functioning for In-Home Testing
MeSA test can be used by healthcare professionals to evaluate the symptoms of ADHD, Dementia and Learning Disorders using an iPad. - September 16, 2020 - BrainTrain, Inc.
A US Patent for Personal Identity Management Using Blockchain Technology Was Granted to DNAtix
Digital DNAtix Ltd., the Israeli startup, announced today the grant of US patent No. US10673847B2 titled, “Systems and methods for user authentication based on a genetic sequence.” The patent is part of the company disruptive and innovative proprietary technology incorporating... - September 11, 2020 - Digital DNAtix Ltd.
Study Points to a New Unexplored Therapeutic Target for C9ORF72-mediated ALS
A novel discovery from scientists at the ALS Therapy Development Institute (ALS TDI) is the first to indicate that asymmetric di-methylation of arginine could be a promising target for ALS therapies. - September 09, 2020 - ALS Therapy Development Institute
Richard W. Bank, M.D. Recognized as a VIP Member for 2020 by Strathmore's Who's Who Worldwide
Richard W. Bank, M.D. of Beverly Hills, California has been recognized as a VIP Member for 2020 by Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements for over 40 years in the field of surgical oncology and as a Portfolio Manager of a dedicated... - September 09, 2020 - Strathmore Worldwide
Paras Biopharmaceuticals Finland Oy Joins PSL Alliance and Its Global Membership to Promote Worldwide Reach Out for Paras’ Bioprocess Enzymes
Paras Biopharmaceuticals Finland Oy (Paras Biopharma) is pleased to announce that it is now a member of the Pivotal Scientific Limited (PSL) Alliance, a network of companies operating within the biotechnology market. As part of the Company’s portfolio of microbial products, technologies and... - September 08, 2020 - Paras Biopharmaceuticals Finland Oy
New eClinical Platform Strategic Analysis & Competitive Landscape Report
Survey Quantifies eClinical Platform Use and Satisfaction and Identifies Dramatic Perceptual Changes - August 26, 2020 - Life Science Strategy Group, LLC
Bench International Brings Diversity of Experience, Ethnicity and Gender with Launch of Executive Recruiting Hub in Boston
Nova Diop Joins Firm to Lead Efforts to Meet Talent Demands of Nation’s Largest Life Science Cluster. - August 17, 2020 - Bench International
THROMBOLEX™ Inc. First Patient Enrolled in the RESCUE Trial for Treatment of Acute Submassive Pulmonary Embolism
THROMBOLEX™ Inc. has announced that it has enrolled the first patient in its pivotal RESCUE trial for the treatment of patients with acute submassive pulmonary embolism (PE) using the BASHIR® Endovascular Catheter, under an Investigational Device Exemption (IDE) from the FDA. RESCUE is a... - August 06, 2020 - Thrombolex, Inc.
Scientists at AbboMax, Inc. Created a TBNK Panel of Monoclonal Antibodies to Study SARS-CoV-2
Understanding of a host immune response to SARS-CoV-2 is extremely important. It was previously shown that the immune system of patients infected by SARS-CoV-2 is severely impaired. In order to better recognize how immune response is orchestrated, the TBNK (B-Cell, T-Cell, and natural killer cells) panel of antibodies created by AbboMax, Inc. can be employed. - July 22, 2020 - AbboMax, Inc.
55 Fitness Adds New Location Through Franchise Expansion
Fitness franchise opportunity opens first of several locations, all targeting ages 55 and older. - July 09, 2020 - 55 Fitness
Local Business Owner David Ho Named to NSBA Leadership Council
Dr. David Ho, Chairman Vietnamese American Business Council was recently named to the National Small Business Association (NSBA) Leadership Council. Dr. Ho, a recognized leader in the small-business community, joins the NSBA Leadership Council alongside other small-business advocates from across the country as they work to promote the interests of small business to policymakers in Washington, D.C. - July 09, 2020 - Vietnamese American Business Council
Bay Area Health Provider Partners with Medicom Health to Lower Medication Cost for Patients
New Electronic Medical Record Add-On Automates the Delivery of Rx Discounts at Enterprise Scale - July 09, 2020 - Medicom Health
EUPROTEIN Launched the Supreme Humanly-Expressed Proteins to Help Research in SARS-CoV-2
EUPROTEIN Inc., the expert in mammalian expressed protein, has launched the full set of their top-quality recombinant proteins to help researchers around the world for their studies towards this global pandemic. These protein are expressed in human mammalian cells, which inherently is of superior quality compared to those expressed from E. Coli. - July 09, 2020 - EUPROTEIN Inc.
THROMBOLEX™ Inc. Receives $3 million Small Business Innovation Research (SBIR) Grant from the NIH to Fund the RESCUE Trial
Thrombolex™ Inc. has announced that it was awarded a $3 million Small Business Innovation Research (SBIR) grant from the National Heart, Lung and Blood Institute (NHLBI) section of the NIH to fund their pivotal RESCUE trial under an IDE for the treatment of up to 125 patients with acute,... - July 07, 2020 - Thrombolex, Inc.
Illinois-Wisconsin Health System Partners with Medicom Health to Lower Patient Prescription Costs
New Electronic Medical Record Add-On Automates the Delivery of Rx Discounts at Enterprise Scale - July 01, 2020 - Medicom Health
Pandemic Experts Launch the American BioDefense Institute
American BioDefense Institute launched as a new model for fighting pandemics. - June 25, 2020 - American BioDefense Institute
BÜHLMANN Laboratories AG Launches New fPELA® turbo Automated, Random Access Pancreatic Elastase Test
BÜHLMANN fPELA® turbo (FDA Exempt. For in vitro Diagnostic Use) is an in vitro diagnostic assay intended for the quantitation of pancreatic elastase in human stool, is now commercially available in the US. - June 24, 2020 - BUHLMANN Diagnostics Corp
Christopher Neary, ND, MSOM, of Bend, Oregon, Announces Partnership with Simpatra.Health
Christopher Neary, ND, MSOM, is the latest physician to join the rapidly expanding Simpatra.Health network. As a member of the Simpatra.Health, Dr. Neary is offering leading edge Bioidentical Hormone Replacement Therapy (BHRT) services and technology to patients throughout Bend and Portland Oregon. - June 22, 2020 - Simpatra
MOC1 Solutions Revolutionizes Hospital Security, Care and Human Resources
MOC1 Solutions announces the availability of a hospital identity and access management solution using artificial intelligence, machine learning and facial recognition into one integrated solution. The Hospital Identity and Access Management System (HIAMS) has become the center of innovation in the... - June 15, 2020 - Mobile Office Communications Inc. DBA MOC1 Solutions
MARUX Announces Filing of Provisional Patent Application for AI Enabled Medical Response, Remote Diagnostics, COVID Vitals
MARUX announced that it has filed a provisional patent application with the United States Patent and Trademark Office, covering machine learning, artificial intelligence, and extended/cross-reality for the Company’s remote medical diagnostics, plus remote monitoring application. This patent application is the second set of software as a service (SaaS) process, and is integral for the Company’s initial augmented reality application focused on automotive. - June 14, 2020 - MARUX Incorporated
HCA Healthcare/HealthONE’s Swedish Medical Center Introduces Minimally Invasive Robotic Tool for Lung Biopsy Procedures
Swedish is the first hospital in Colorado to offer robotic assisted technology that will help detect lung cancer earlier and improve outcomes. - June 13, 2020 - Swedish Medical Center